Distinguished Lecture Series

Knight Campus Distinguished Lecture Series

 

"Transforming our World for a Better Tomorrow"

Distinguished Lecture Series with Susan Margulies

When: Thursday, Nov. 10, 2022 | 3 p.m. - 4 p.m.
Where: Beetham Family Seminar Room at the Knight Campus

 

Dr. Susan Margulies, Assistant Director for Engineering of the National Science Foundation (NSF), will discuss priorities and opportunities for engineering research and education in her talk,"Transforming our World for a Better Tomorrow."

Internationally recognized for pioneering studies spanning the micro-to-macro scales and across species, Margulies' research seeks to identify mechanisms underlying brain injuries in children and adolescents and lung injuries associated with mechanical ventilation, leading to improved injury prevention, diagnosis and treatments. She joined the NSF as the assistant director for the Directorate for Engineering in August 2021 after leading the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University. While on detail at the NSF, she is a professor and Georgia Research Alliance Eminent Scholar at Georgia Tech and Emory.

Margulies leads the U.S. National Science Foundation’s Directorate for Engineering in its mission to transform our world for a better tomorrow by driving discovery, inspiring innovation, enriching education, and accelerating access. With an annual budget of nearly $800 million, the NSF’s Engineering Directorate provides over 40 percent of federal funding for fundamental research in engineering at academic institutions, and it distributes more than 1500 awards supporting research and education each year. Projects funded by the Engineering Directorate span frontier research to generate new knowledge, problem-driven research to identify new solutions to societal challenges, and application-driven research to translate discoveries to uses that benefit society.

 

Susan Margulies received her B.S.E. in mechanical and aerospace engineering at Princeton University, her Ph.D. in bioengineering from the University of Pennsylvania, and post-doctoral training at the Mayo Clinic. She joined the faculty at the University of Pennsylvania in 1993 as an assistant professor, rising through the ranks to professor. In 2017 she became the first faculty member tenured in both the Georgia Institute of Technology and Emory University, and she was a department chair in both the college of engineering at Georgia Tech and Emory’s school of medicine. She has launched numerous training and mentorship programs for students and faculty, created institute-wide initiatives to enhance diversity and inclusion, and led innovative projects in engineering education. Margulies’ transdisciplinary scholarly impact has been recognized by her election as fellow of the American Society of Mechanical Engineers, the Biomedical Engineering Society, and the American Institute for Medical and Biological Engineering, and as a member of the National Academy of Engineering and the National Academy of Medicine. 

The Knight Campus Distinguished Lecture is an annual event designed to bring nationally and internationally recognized science, technology and engineering leaders to the University of Oregon community to give their perspective on the future of their fields.


Thank you for joining us for the Knight Campus' 2022 Distinguished Lecture Series seminar. Stay tuned to this website for a video archive of Dr. Margulies' talk.

 

Susan Margulies

 

Previous Speakers

Karen Wooley

W.T. Doherty-Welch Chair in Chemistry and Distinguished Professor, Texas A&M University

"Synthetic Strategies to Afford Natural Product-Based Polymer Materials: Impacts on Sustainability, Life, Health and the Environment"

Karen Wooley discusses how natural polymer materials can impact sustainability, human health, and the environment.

Watch this Presentation

Brian Druker

Director, Knight Cancer Institute

"Imatinib as a Paradigm of Targeted Cancer Therapies"

Brian Druker discussed how he spearheaded the highly successful clinical trials of imatinib for chronic myeloid leukemia, which led to FDA approval of the drug in record time.

Watch this Presentation

stephen gillet
Stephen Gillett

CEO and Co-Founder, Chronicle

"Innovation, Leadership, and Change"

Stephen Gillett discussed leadership, transformation, and change and how these elements shaped him into a leader that skirts the norm, strives for innovation, and views change as an opportunity, not a roadblock.